Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
The cyclin D1 (CCND1) gene contains a frequent A/G polymorphism within the splice donor region of exon 4/intron 4. CCND1 genotype is associated with clinical outcome in a number of malignancies although prognostic significance varies with tumour type. We examined CCND1 allele frequencies and genotyp...
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
2001
|
| _version_ | 1826288795994030080 |
|---|---|
| author | Simpson, D Fryer, A Grossman, AB Wass, J Pfeifer, M Kros, J Clayton, R Farrell, W |
| author_facet | Simpson, D Fryer, A Grossman, AB Wass, J Pfeifer, M Kros, J Clayton, R Farrell, W |
| author_sort | Simpson, D |
| collection | OXFORD |
| description | The cyclin D1 (CCND1) gene contains a frequent A/G polymorphism within the splice donor region of exon 4/intron 4. CCND1 genotype is associated with clinical outcome in a number of malignancies although prognostic significance varies with tumour type. We examined CCND1 allele frequencies and genotype distribution in 294 patients with sporadic pituitary adenomas of various histologies. CCND1 allele frequencies and distribution of genotypes were similar in the 294 cases compared with previously reported control populations. Analysis according to tumour subtype showed no statistical difference in allele frequencies compared with controls. However, CCND1 genotype distribution in the somatotrophinomas showed a significant difference compared with normal controls (P = 0.008). We next examined CCND1 allele frequencies and genotype distribution across the tumour grades. Within the total tumour cohort the CCND1 allele frequencies showed a significant inverse relationship across the tumour grades (P = 0.005). The CCND1 A allele progressively increased from grade 1 (0.37) through to grade 4 (0.62) tumours, whilst the CCND1 G allele frequency progressively decreased from grade 1 (0.63) through to grade 4 (0.38) tumours. Trend analysis of CCND1 genotypes showed a significant progressive increase in AA frequency from grade 1 (15%) through to grade 4 (46%) tumours (P = 0.005). The CCND1 GG genotype progressively decreased from grade 1 (41%) through to grade 4 (23%) tumours (P = 0.204). No statistical significance was observed between CCND1 AG genotype and tumour grades. While the functional significance of the observed segregation of the CCND1 A/G polymorphism and tumour grade is unclear, our data suggest that CCND1 allele frequencies and genotype distributions show significant differences between tumour grades in sporadic pituitary adenomas. Since CCND1 genotype may be determined by analysis of peripheral blood samples it may provide a useful predictive marker for those tumours likely to show invasive behaviour. This may be clinically useful in indicating which tumours should receive adjunctive treatment (e.g. radiotherapy) immediately after surgical resection. |
| first_indexed | 2024-03-07T02:19:06Z |
| format | Journal article |
| id | oxford-uuid:a34b369c-6efd-43d0-9a03-99d79feb334a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:19:06Z |
| publishDate | 2001 |
| record_format | dspace |
| spelling | oxford-uuid:a34b369c-6efd-43d0-9a03-99d79feb334a2022-03-27T02:25:53ZCyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a34b369c-6efd-43d0-9a03-99d79feb334aEnglishSymplectic Elements at Oxford2001Simpson, DFryer, AGrossman, ABWass, JPfeifer, MKros, JClayton, RFarrell, WThe cyclin D1 (CCND1) gene contains a frequent A/G polymorphism within the splice donor region of exon 4/intron 4. CCND1 genotype is associated with clinical outcome in a number of malignancies although prognostic significance varies with tumour type. We examined CCND1 allele frequencies and genotype distribution in 294 patients with sporadic pituitary adenomas of various histologies. CCND1 allele frequencies and distribution of genotypes were similar in the 294 cases compared with previously reported control populations. Analysis according to tumour subtype showed no statistical difference in allele frequencies compared with controls. However, CCND1 genotype distribution in the somatotrophinomas showed a significant difference compared with normal controls (P = 0.008). We next examined CCND1 allele frequencies and genotype distribution across the tumour grades. Within the total tumour cohort the CCND1 allele frequencies showed a significant inverse relationship across the tumour grades (P = 0.005). The CCND1 A allele progressively increased from grade 1 (0.37) through to grade 4 (0.62) tumours, whilst the CCND1 G allele frequency progressively decreased from grade 1 (0.63) through to grade 4 (0.38) tumours. Trend analysis of CCND1 genotypes showed a significant progressive increase in AA frequency from grade 1 (15%) through to grade 4 (46%) tumours (P = 0.005). The CCND1 GG genotype progressively decreased from grade 1 (41%) through to grade 4 (23%) tumours (P = 0.204). No statistical significance was observed between CCND1 AG genotype and tumour grades. While the functional significance of the observed segregation of the CCND1 A/G polymorphism and tumour grade is unclear, our data suggest that CCND1 allele frequencies and genotype distributions show significant differences between tumour grades in sporadic pituitary adenomas. Since CCND1 genotype may be determined by analysis of peripheral blood samples it may provide a useful predictive marker for those tumours likely to show invasive behaviour. This may be clinically useful in indicating which tumours should receive adjunctive treatment (e.g. radiotherapy) immediately after surgical resection. |
| spellingShingle | Simpson, D Fryer, A Grossman, AB Wass, J Pfeifer, M Kros, J Clayton, R Farrell, W Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. |
| title | Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. |
| title_full | Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. |
| title_fullStr | Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. |
| title_full_unstemmed | Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. |
| title_short | Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. |
| title_sort | cyclin d1 ccnd1 genotype is associated with tumour grade in sporadic pituitary adenomas |
| work_keys_str_mv | AT simpsond cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT fryera cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT grossmanab cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT wassj cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT pfeiferm cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT krosj cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT claytonr cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas AT farrellw cyclind1ccnd1genotypeisassociatedwithtumourgradeinsporadicpituitaryadenomas |